• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS SYPHILIS ELECSYS E2G 300; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS SYPHILIS ELECSYS E2G 300; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM Back to Search Results
Model Number SYPHILIS E2G
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/07/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that the calibration and qc were acceptable.The investigation is ongoing.The event occurred in (b)(6).
 
Event Description
The initial reporter complained of questionable results for 1 patient tested for syphilis elecsys on a cobas 8000 e 801 module serial number (b)(4) compared the pcr method.The initial syphilis result was (b)(6) and the pcr treponema pallidum result was (b)(6).A new sample was collected.On (b)(6) 2019 the syphilis result for the new sample was (b)(6) and the pcr treponema pallidum result was (b)(6).The (b)(6) syphilis result was reported outside of the laboratory.The physician questioned the result.There was no allegation of an adverse event.
 
Manufacturer Narrative
The customer provided two samples for investigation.The samples were non-reactive for elecsys syphilis assay and all non-treponemal assays but reactive when tested using the competitor¿s treponemal assays.In this investigation the specific igm antigens showed reactivity with the first sample, while the igg- specific antigens remain non-reactive.The second draw shows an increase in igm reactivity and a slight increase in one igg specific-antigen.These findings indicate the possibility of an early phase of syphilis infection.The package insert addresses the possibility of a false non-reactive results: "a negative test result does not completely rule out the possibility of an infection with treponema pallidum.Serum or plasma samples from the very early (pre-seroconversion) phase or the late phase of a syphilis infection can occasionally yield negative findings." the reagent performs within specification.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYPHILIS ELECSYS E2G 300
Type of Device
ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key8784449
MDR Text Key150874647
Report Number1823260-2019-02567
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
PMA/PMN Number
K160910
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 10/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/12/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSYPHILIS E2G
Device Catalogue Number07251378190
Device Lot Number370224
Date Manufacturer Received06/21/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PENICILLIN; PENICILLIN
Patient Age68 YR
-
-